Company Overview

Polygenetics International, Inc., through its subsidiary, Polygenetics, Inc., engages in developing and licensing porous polymers for pharmaceutical and bio-medical applications. It develops and patents technologies and offers licenses to companies interested in exclusive patent protection for particular applications. The company principally focuses on drug delivery methods that involves in its patented porous polymer materials, which act as drug reservoirs and permit near zero-order release of active components. Its porous polymers include Cavilink, which has interconnected cavities suited to growing cells, such as spheroid shaped hepatocytes in performing liver-specific functions and chond...

Polygenetics International, Inc., through its subsidiary, Polygenetics, Inc., engages in developing and licensing porous polymers for pharmaceutical and bio-medical applications. It develops and patents technologies and offers licenses to companies interested in exclusive patent protection for particular applications. The company principally focuses on drug delivery methods that involves in its patented porous polymer materials, which act as drug reservoirs and permit near zero-order release of active components. Its porous polymers include Cavilink, which has interconnected cavities suited to growing cells, such as spheroid shaped hepatocytes in performing liver-specific functions and chondrocytes. These polymer substrates could transmit modified viruses and protect them from the immune system of the host. The company also develops Cavilink microspheres, which receives living cells into their cavities and allowing those cells to proliferate. Polygenetics International was founded in 1993 and is based in Los Gatos, California.

Key Executives for Polygenetics International Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions